Evidence map›Paper›PMID 41846317›Full record

ArticleHGG advances2026

Breaking barriers to completing genetic testing for inherited breast cancer among at-risk Black women using a community-based participatory research approach.

Sarah H Choi, Sanjana Ramesh, Shanequa Reed, Georgina Menyah, Pamela Ganschow, Vida Henderson, Henry M Dunnenberger

Abstract read
In one paragraph

Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah H ChoiNeaman Center for Personalized Medicine, Endeavor Health, Evanston, IL 60201, USA. Electronic address: sarah.choi@endeavorhealth.org.
Sanjana RameshNeaman Center for Personalized Medicine, Endeavor Health, Evanston, IL 60201, USA.
Shanequa ReedNeaman Center for Personalized Medicine, Endeavor Health, Evanston, IL 60201, USA.
Georgina MenyahIn the Know, Inc., Chicago, IL 60607, USA.
Pamela GanschowInternal Medicine, University of Illinois Cancer Center, Chicago, IL 60612, USA.
Vida HendersonCancer Prevention Program, Public Health Sciences Division, Fred Hutch, Seattle, WA 98109, USA.
Henry M DunnenbergerNeaman Center for Personalized Medicine, Endeavor Health, Evanston, IL 60201, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

National guidelines from the US Preventive Services Task Force and the National Comprehensive Cancer Network recommend the use of family-health-history (FHH)-based risk assessment tools to guide genetic testing (GT) among women with an increased risk of inherited cancer and inform personalized cancer risk management. Prior research has focused on attitudes toward and decisions about initial uptake of GT in Black patients but little is known about the factors that impact the subsequent completion of GT after they have already provided consent. Using a community-based participatory research (CBPR) approach, we aimed to identify barriers and actionable strategies to improve GT completion offered through the Breast Health Assessment (BHA), an FHH screening tool administered at routine mammography visits. We conducted semi-structured interviews with 12 Black women who screened high-risk for inherited breast cancer and consented to GT through the BHA, but did not complete saliva sample collection. Thematic analysis revealed that lack of dedicated support throughout the BHA workflow emerged as a key obstacle to sample collection, whereas medical mistrust, shame, and limited knowledge were largely regarded as cultural barriers that had no impact on GT completion. Low utilization among participants reflected logistical challenges highlighting the need to evaluate multi-level implementation processes to better understand and address inequities in GT completion. Participants suggested implementing early educational outreach, culturally relevant messaging, and interpersonal touchpoints to promote GT uptake. By applying a CBPR approach, we translated these findings into actionable, equity-focused strategies to improve GT completion within a population genetic screening program.

Indexed as

Black or African AmericanBreast NeoplasmsGenetic Predisposition to DiseaseGenetic TestingAdultCommunity-Based Participatory ResearchEarly Detection of CancerFemaleHumansMiddle AgedBlack womencommunity-based participatory researchfamily-health-history screeninggenetic testinghealth services implementationinherited breast cancerpopulation genetic screeningprecision medicinequalitative researchscreening mammography

Identifiers

PMID41846317
PMCPMC13071439

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.